A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1)
Public ClinicalTrials.gov record NCT06687967. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of Dupilumab for the Treatment of Pruritus of Lichen Simplex Chronicus (LSC) in Adults
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a parallel, Phase 3, 2-arm study for treatment. The purpose of this study is to measure improvement in pruritus with dupilumab subcutaneous injections compared with placebo injections in male and female participants aged at least 18 years with LSC. Study details include: The study duration will be up to 40 weeks. The treatment duration will be up to 24 weeks. The follow-up duration after treatment will be 12 weeks. The number of visits will be 6.
Study identification
- NCT ID
- NCT06687967
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 142 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 28, 2024 (Actual)
- Primary completion
- Jun 8, 2026 (Actual)
- Completion
- Aug 31, 2026 (Actual)
- Last update posted
- Sep 11, 2026
2024 – 2026
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dermatology Research Associates - Los Angeles- Site Number : 8400004 | Los Angeles | California | 90045 | — |
| Quality Care Clinical Research- Site Number : 8400034 | Miami | Florida | 33142 | — |
| Michigan Center for Research Company- Site Number : 8400013 | Clarkston | Michigan | 48346 | — |
| JDR Dermatology Research- Site Number : 8400023 | Las Vegas | Nevada | 89145 | — |
| Equity Medical- Site Number : 8400017 | New York | New York | 10023 | — |
| Onsite Clinical Solutions - Huntersville- Site Number : 8400033 | Huntersville | North Carolina | 28078 | — |
| Wake Forest University Health Sciences- Site Number : 8400028 | Winston-Salem | North Carolina | 27104 | — |
| Red River Research Partners - Fargo- Site Number : 8400007 | Fargo | North Dakota | 58103 | — |
| Center for Clinical Studies - Houston - Binz Street- Site Number : 8400011 | Houston | Texas | 77004 | — |
| MedCare Pharma - Houston - Cypress Creek Parkway- Site Number : 8400014 | Houston | Texas | 77090 | — |
| Care Access - Arlington- Site Number : 8400022 | Arlington | Virginia | 22206 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06687967, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 11, 2026 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06687967 live on ClinicalTrials.gov.